BCL2 and Miyoshi myopathy: A phase Ib study of S-65487 (a Bcl-2 inhibitor) in combination with MIK665 in patients with relapsed/refractory MM, acute myeloid leukemia, and non-Hodgkin lymphoma is actively recruiting participants (NCT04702425).